These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28583767)

  • 1. LXR-dependent regulation of macrophage-specific reverse cholesterol transport is impaired in a model of genetic diabesity.
    Errico TL; Méndez-Lara KA; Santos D; Cabrerizo N; Baila-Rueda L; Metso J; Cenarro A; Pardina E; Lecube A; Jauhiainen M; Peinado-Onsurbe J; Escolà-Gil JC; Blanco-Vaca F; Julve J
    Transl Res; 2017 Aug; 186():19-35.e5. PubMed ID: 28583767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic ABCG5/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT.
    Dikkers A; de Boer JF; Groen AK; Tietge UJ
    Atherosclerosis; 2015 Dec; 243(2):402-6. PubMed ID: 26520893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8.
    Calpe-Berdiel L; Rotllan N; Fiévet C; Roig R; Blanco-Vaca F; Escolà-Gil JC
    J Lipid Res; 2008 Sep; 49(9):1904-11. PubMed ID: 18509196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cholesterol content of Western diets plays a major role in the paradoxical increase in high-density lipoprotein cholesterol and upregulates the macrophage reverse cholesterol transport pathway.
    Escolà-Gil JC; Llaverias G; Julve J; Jauhiainen M; Méndez-González J; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2493-9. PubMed ID: 21885848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-specific Lxr inhibition represses reverse cholesterol transport in cholesterol-fed mice.
    Nishida T; Ayaori M; Arakawa J; Suenaga Y; Shiotani K; Uto-Kondo H; Komatsu T; Nakaya K; Endo Y; Sasaki M; Ikewaki K
    Atherosclerosis; 2024 Oct; 397():117578. PubMed ID: 38797615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice.
    Wiersma H; Gatti A; Nijstad N; Oude Elferink RP; Kuipers F; Tietge UJ
    Hepatology; 2009 Oct; 50(4):1263-72. PubMed ID: 19637290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists.
    Srivastava RAK; Cefalu AB; Srivastava NS; Averna M
    Mol Cell Biochem; 2020 Oct; 473(1-2):247-262. PubMed ID: 32661772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
    Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
    Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment.
    Altemus JB; Patel SB; Sehayek E
    Metabolism; 2014 Oct; 63(10):1334-41. PubMed ID: 25060694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice.
    Plösch T; van der Veen JN; Havinga R; Huijkman NC; Bloks VW; Kuipers F
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G414-23. PubMed ID: 16614371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice.
    Dikkers A; Freak de Boer J; Annema W; Groen AK; Tietge UJ
    Hepatology; 2013 Jul; 58(1):293-303. PubMed ID: 23401258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cholesterol-free, high-fat diet suppresses gene expression of cholesterol transporters in murine small intestine.
    de Vogel-van den Bosch HM; de Wit NJ; Hooiveld GJ; Vermeulen H; van der Veen JN; Houten SM; Kuipers F; Müller M; van der Meer R
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1171-80. PubMed ID: 18356535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta.
    Repa JJ; Berge KE; Pomajzl C; Richardson JA; Hobbs H; Mangelsdorf DJ
    J Biol Chem; 2002 May; 277(21):18793-800. PubMed ID: 11901146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
    Hsieh J; Koseki M; Molusky MM; Yakushiji E; Ichi I; Westerterp M; Iqbal J; Chan RB; Abramowicz S; Tascau L; Takiguchi S; Yamashita S; Welch CL; Di Paolo G; Hussain MM; Lefkowitch JH; Rader DJ; Tall AR
    Nature; 2016 Jul; 535(7611):303-7. PubMed ID: 27383786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Ceramide Decreased the Expression of ATP-Binding Cassette Transporter G5/8 mRNA in an Animal Model of Cholesterol Gallstone.
    Kim HJ; Kim JS; Oh S; Yoo HS
    Dig Dis; 2017; 35(5):439-443. PubMed ID: 28268212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCG5/ABCG8 in cholesterol excretion and atherosclerosis.
    Yu XH; Qian K; Jiang N; Zheng XL; Cayabyab FS; Tang CK
    Clin Chim Acta; 2014 Jan; 428():82-8. PubMed ID: 24252657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing
    Kikuchi T; Orihara K; Oikawa F; Han SI; Kuba M; Okuda K; Satoh A; Osaki Y; Takeuchi Y; Aita Y; Matsuzaka T; Iwasaki H; Yatoh S; Sekiya M; Yahagi N; Suzuki H; Sone H; Nakagawa Y; Yamada N; Shimano H
    Mol Metab; 2016 Nov; 5(11):1092-1102. PubMed ID: 27818935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients.
    Geuken E; Visser DS; Leuvenink HG; de Jong KP; Peeters PM; Slooff MJ; Kuipers F; Porte RJ
    Hepatology; 2005 Nov; 42(5):1166-74. PubMed ID: 16250035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice.
    Kruit JK; Plösch T; Havinga R; Boverhof R; Groot PH; Groen AK; Kuipers F
    Gastroenterology; 2005 Jan; 128(1):147-56. PubMed ID: 15633131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
    Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
    Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.